Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2018 / Article

Research Article | Open Access

Volume 2018 |Article ID 3927075 | 8 pages | https://doi.org/10.1155/2018/3927075

Extraction of Amana edulis Induces Liver Cancer Apoptosis

Academic Editor: Ling Yang
Received03 Mar 2018
Accepted30 Apr 2018
Published04 Jul 2018

Abstract

HCC is one of the fastest-rising causes of cancer-related death. Novel therapeutic approaches for treatment are warranted. The goal of this study is to find effective components from Chinese herbal medicines, which is an important alternative source of anticancer medicine. To this end, six different herbs were selected from various traditional literatures. Soxhlet extractor was used to distill the strong polar and weak polar components of each herb. The inhibitive effect of each component was determined using liver cancer cells BEL7404. From total of 12 extractions, it was found that the combined crude lysate of Amana edulis from water and ethanol system had the best efficacy. At the concentration of 0.1 mg/mL, this component has the highest inhibition rate up to 70%. To investigate the underlying molecular reasons, we observed that the component can significantly induce the liver cancer cells apoptosis and retard the cell reproduction at G2/M stage. Verification experiments showed that this component also has apparent inhibitive effects on other liver cancer cells, such as HepG2 and Huh7. On the other hand, it has less effectiveness on another cell line HepaRG, which retains many characteristics of primary human hepatocytes. The results suggested that there might be highly efficient antihepatoma ingredient in the water and ethanol extraction of Amana edulis. The pure substances remain to be isolated and further research on their targets is required.

1. Introduction

Hepatocellular carcinoma (HCC) has become one of the leading causes of death and an important public health problem in China because of the increasingly higher morbidity and mortality rates. It was reported that the death number from HCC ranks second in China, while the current treatment and drug R&D remain backward [1]. Many HCC were detected at advanced stage due to its extended initiation and progression times, with poor liver function, high tumor recurrence rate, and metastasis. Unfortunately, most advanced HCC are unresectable [2]. A variety of therapies have been used for the treatment of liver cancer, such as chemotherapy, radiotherapy, cryo-ablation, and transcatheter arterial chemoembolization (TACE) [3]. However, the effects of these treatments are poor due to unresponsiveness of HCC cells and are often accompanied by multiple side effects including bone marrow depression, hair loss, postembolization syndrome, and liver and renal failure.

Traditional Chinese medicine (TCM) is a medical science studying disease prevention, diagnosis and treatment, rehabilitation, and health preservation. It has been used in China for thousands of years [46]. It has made a significant contribution to the treatment of various diseases [7]. Herbal medicine is one of the major components in TCM. It was originated from the first literature of Shennong’s Materia Medica (~220 CE). Herbal medicine is an important treasure of Chinese nation, which has been used for thousands of years and gained remarkable effects on the treatment of various diseases including tumor, due to accumulating abundant theoretical and practical knowledge through thousands of years [8], and the abundant herb resource has also provided essential material foundation to look for new anticancer drugs [911]. The modern success of using taxol and artemisinin further proves its value. A plenty of Chinese herbs medicines have been proved effective in treating liver diseases. Research results also showed that some Chinese herbal medicines are commonly used for patients with HCC in the clinical practice of Chinese medicine practitioners [12]. HCC is deadly and has become a public health problem. However, most antitumor drugs in clinical cases, including molecular targeted drug and antibody drug, are Western medicine, only a few native compounds or their derivatives with significant effect. Thus, in the present study, we got the idea for research on fighting against cancer with Chinese medicine. We plan to look for less-focused Chinese medicinal herbs with potential antitumor activity by consulting classic ancient literatures about Chinese herbal medicine for separation and purification of active components to research their antitumor activity, anticipating to find new natural products with anticancer activity.

Although there are few records of such disease names of “tumor” or “cancer” in traditional medical works, the description of occurrence, development, diagnosis, and treatment to many diseases, such as “Yingliu” (goiter), “Luoli” (scrofula), “Zhengjiajiju”(gynecologic abdominal agglomerate), and “Yeshi” (oesophageal carcinoma), is of high similarity to “tumor” and “cancer” in modern medicine. Hereby, in the present study, by consulting a massive of ancient literatures, including “Treatise on Febrile Diseases (Shanghan Lun)”, “Huangdi’s Canon of Medicine”, and “Compendium of Materia Medica”, we selected these medicinal herbs of Amana edulis, Prunella vulgaris L., Vaccaria segetalis (Neck.) Garcke, Gnaphalium affine D. Don, Paeonia lactiflora Pall., and Bupleurum chinense DC by taking the words of “Jiju, Jiejie, and Zhengjia” as the basis and under the principle of “no repetitive, effectiveness, hypotoxicity, and nonscarcity”.

We identified that the combined crude lysate of Amana edulis from water and ethanol system had the highest inhibition efficacy. Our results further showed that crude lysate of Amana edulis could significantly induce the liver cancer cells into early and late stage apoptosis and retard the cell reproduction at G2/M stage. These data suggested that there may be highly efficient antihepatoma component in Amana edulis.

2. Materials and Methods

2.1. Experimental Materials and Reagents

Amana edulis, Prunella vulgaris L., Vaccaria segetalis (Neck.) Garcke, Gnaphalium affine D. Don, Paeonia lactiflora Pall., and Bupleurum chinense DC were all purchased from Tongrentang Pharmacy and kept in an airtight device for a period of time before processing.

2.2. Cell Culture

The human hepatoma cell lines of BEL7404 were cultured in Roswell Park Memorial Institute (RPMI) 1640 Medium supplemented with 10% fetal bovine serum (FBS) [13, 14] and incubated under the condition of 5% CO2 humidified atmosphere at 37°C with saturated humidity [15, 16].

2.3. Soxhlet Extraction Method

100g of Chinese herbal medicines was extracted using ethanol-water solvent mixed system (100mL of water and 100mL of ethyl alcohol) and petroleum ether-ethyl acetate mixed system (100mL of petroleum ether and 100mL of ethyl acetate) for 120min by heat reflux extraction, respectively. Then solvents were removed with vacuum rotary evaporation. The extractions were kept at −20°C until used.

2.4. Cell Viability Assay

Cell Counting Kit-8 was used to evaluate the cytotoxicity of Amana edulis, as described in a previous paper [17]. Cells were seeded in 96-well plates at 20,000 cells per well and added various concentrations of Amana edulis and incubated for 24h. CCK-8 solution was added to each well and the plate is placed in the incubator for 4h after which the absorbance was read at 450nm using VERSAmax tunable microplate reader (Sunnyvale, CA, USA).

2.5. MTT Assay

In order to further verify the cell proliferation of crude lysate of Amana edulis, 3-(4,5-dimethylthiazol-2-yl)-2,3-diphenyl tetrazolium bromide (MTT) assay was conducted in accordance with a previously described method [18] in the four cell lines of BEL7404, HepG2, Huh7, and HepaRG cells. Briefly, 1×104 cells in 100 μL medium were plated into each well of 96-well plates (five wells per group). 24h after plating, 10μL 0.5mg/mL MTT solution was added to each culture well, and then the cells were incubated at 37°C for 4h. Then, the MTT solution in each culture well was removed. Finally, 150μL of DMSO was added to each culture well, and the mixtures were shaken. The absorbance was measured on a microplate reader (Multiskan Spectrum; Thermo Fisher, Waltham, MA, USA) at 540nm.

2.6. Annexin V-FITC Assay

Cell apoptosis was analyzed using the Annexin V-FITC/PI Apoptosis Detection Kit according to the manufacturer’s protocol (Sigma-Aldrich Co., St. Louis, MO) with slight modifications. Briefly, BEL7404 cells were plated in 96-well plates at a density of 4×105 cells/mL. After 24-hour incubation, cells were treated with crude lysate of Amana edulis and then incubated at 37°C for 24h. Cells were harvested by trypsinization and centrifugation, and cell supernatant was abandoned. The cells were washed three times with the precold PBS buffer, and the cells density was adjusted to 1×106 cell/mL. Then Annexin V and PI solution were added to the cells at room temperature without light exposure for 15min. Cell apoptosis was determined using flow cytometer (EasyCyte guava, Merck Millipore).

2.7. Cell Cycle Analysis

Cells were seeded in 96-well plates at a density of 4×105 cells/mL and incubated at 37°C to allow cells to grow to 60%–80% confluence. Cells were treated with crude lysate of Amana edulis for 24h. Cells were collected by digestion and fixed with 70% ethanol at 4°C overnight. Then the cells were resuspended in phosphate-buffered saline (PBS) and incubated at 37°C for 1h. Finally, the cells were stained with propidium iodide (PI) for 30min without light exposure. Stained cells were analyzed by flow cytometer (EasyCyte guava, Merck Millipore). ModFit Cell Cycle Analysis software was used to analyze the percentage of cells in G1, G2, and S phases based on DNA content.

2.8. Statistical Analyses

The experiments were repeated three times, and the data represent the means. The results were analyzed using one-way ANOVA followed by Student’s t-test [19, 20]. An inspection level was considered to indicate a significant difference when p < 0.05 [21, 22].

3. Results

3.1. The Inhibition Rate of Six Ingredients

We selected six kinds of Chinese medicine herbals, which were highly correlated with liver cancer, and with no repetitive, effectiveness, hypotoxicity, and nonscarcity (Figure 1).

As shown in Table 1, two kinds of methods, water-ethanol and petroleum ether-ethyl acetate, were used to obtain crude extraction. The inhibitory effects of six ingredients were determined. All ingredients showed significant ability to inhibit the growth of BEL7404 at the concentration of 10mg/mL, whilst only Prunella vulgaris L., Paeonia lactiflora Pall., and Amana edulis in water-ethanol solvent and Prunella vulgaris L. and Vaccaria segetalis (Neck.) Garcke in Petroleum Ether-ethyl acetate retained the ability at the concentration of 0.1mg/mL. We evaluated the effect of Amana edulis on the growth of the BEL7404 cells, and the data showed that IC50 of Amana edulis after being treated for 24h in BEL7404 cells was 0.052mg/mL (Figure 2(a)), which indicated that the crude extraction of Amana edulis is able to suppress the growth of BEL7404 cell lines. Moreover, Amana edulis shows the highest efficiency in the inhibition of the proliferation of liver cancer cells at the concentration of 0.1 mg/mL (Figure 2(b)).


IngredientsInhibition Rate, %
Water-EthanolPetroleum Ether-Ethyl Acetate
0.1 mg/mL10 mg/mL0.1 mg/mL10 mg/mL

Prunella vulgaris L.100%100%50%90%
Vaccaria segetalis (Neck.) Garcke0%100%90%100%
Gnaphalium affine D. Don0%90%0%100%
Amana edulis100%100%50%100%
Bupleurum chinense DC.0%90%0%100%
Paeonia lactiflora Pall.100%100%0%90%

3.2. The Crude Extraction of Amana edulis Induces DNA Fragmentation

To observe and measure the effect of Amana edulis on hepatoma carcinoma cell DNA, agarose gel electrophoresis had been implemented. The comet tails of the experiment group, which was treated with 0.1 mg/mL crude extraction of Amana edulis, was obviously longer than control group (Figure 3). Moreover, our results indicated that the DNA fragmentation may happen as early as 12h posttreatment, and Amana edulis may induce BEL7404 cells apoptosis.

3.3. The Crude Extraction of Amana edulis Induces Early and Late-Age Apoptosis of BEL7404 Cells

In order to explore the mechanism of apoptosis, Annexin V-FITC-PI Apoptosis Detection Kit was used to check whether apoptosis was induced.

The flow cytometry data showed that early apoptosis values are 3.49% to 24.70% with beginning and ending difference of 7.08 times, and late apoptosis values are 2.41% to 18.70% with beginning to ending difference of 7.76 times (Figure 4). These results indicated that Amana edulis (water-ethanol) mixed system extract can significantly induce early and late-age apoptosis of BEL7404 cells.

3.4. The Crude Lysate of Amana Edulis Retards the Cell Reproduction at G2/M Stage

To investigate the inhibition mechanism of the crude lysate of Amana Edulis mediated cell cycle arrest at the G2/M phase, cell cycle assay was carried out. Amana edulis (water-ethanol) extract significantly arrested BEL7404 cells at G2/M phase after 24 hours’ action, which may inhibit related protein activity during the division cycle (Figure 5).

3.5. The Crude Lysate of Amana edulis Has Inhibitory Effects on Other Liver Cancer Cell Lines

To investigate whether this ingredient would have effect on other cell lines, human liver cancer cells BEL7404, HepG2, and Huh7 and normal liver cell HepaRG were used to conduct the verification experiment through MTT assay and t-test. The survival rate of HepaRG cell was the highest, followed by HepG2 cell, and the survival rate of Huh7 cell was the lowest (Figure 6). The results showed that the inhibition effect of Amana edulis (water-ethanol) mixed system extract on liver cancer cells have extremely significant difference compared with normal cells.

4. Discussion

Hepatocellular carcinoma (HCC) is a common malignant disease and is famous for its high incidence and mortality rates [23]. Moreover, at present, the therapeutic strategy available for the treatment of HCC is limited. A report showed that surgical intervention is currently one of the most effective methods for the treatment of HCC [24]. It is unfortunate that only a few patients with liver cancer are eligible for surgical treatment, because HCC is usually diagnosed at a late stage, due to the unresponsiveness of HCC cells. Therefore, systemic chemotherapy is still in the dominant position for the majority of patients, who is suffering from the injury of hepatocellular carcinoma [25]. However, It is well known that chemotherapy is doing harm to the body of the HCC patient and often accompanied with many side effects Therefore, it is a matter of great urgency to carry out research on hepatoma treatment, and new drug targets as well as chemical entities are in desperate need.

Chinese herbal medicine has been actively researched through various approaches. It has been increasingly accepted that Chinese herbal medicine plays an effective function in fighting against various diseases with low side effects, including HCC. In addition, it had been widely reported that some Chinese herbal medicines had an ability to inhibit the HCC at preclinical and clinical levels [12, 26]. Paeonia lactiflora Pall. root had been proved to be a component of effective prescriptions for treatment of liver disease [7]. Astragalosides, the extractive of Radix Astragali, significantly induced apoptosis and inhibited invasion of tumor cells [27, 28].

Some Chinese herbal medicines in this study have been widely studied and even have been used in clinics. The extracts of Prunella vulgaris L. have multitarget and multipathway effects on antilung adenocarcinoma due to the regulation of steady state of calcium ion, cell cycle, and its steady state and the inhibition of tumor cell proliferation and metastasis [29]. The Gnaphalium affine D. Don is a folk medicine and used to treat antiinflammatory, and expectorant activities, and the extract of Gnaphalium affine D. Don showed significant antiinflammatory activity and reduced the paw swelling on MSU crystal-induced paw edema model [30]. Polysaccharides fractionated from roots of Bupleurum chinense DC present anticomplementary activity in vitro [31]. Vaccaria segetalis (Neck.) Garcke [32] and Paeonia lactiflora Pall. [33] were also extensively research.

Amana edulis has the effects of clearing heat, dissipating phlegm, and resolving masses with meridian distribution of liver and spleen, which is one of the anticancer Chinese medicinal herbs. In this study, our data indicated that six kinds of Chinese herbal medicines were certain antihepatoma effects, finding Amana edulis (water-ethanol) mixed system extract has the highest efficiency in the inhibition of the proliferation of liver cancer at the concentration of 0.1mg/mL. However, the effect of Amana edulis (water- ethanol) mixed system extract should be further investigated.

In this study, it was also observed that DNA showed a long tail in Amana edulis (water-ethanol) mixed system extract. These extracts can also increase early and late-age apoptosis rates and induce cell cycle arrest at the G2/M phase, indicating Amana edulis (water-ethanol) mixed system extract that may induce apoptosis. As is known to all, the proliferation and apoptosis of tumor cells are closely related to the regulation of cell cycle. For cancer cells, the blocking effect is an important index to evaluate the effect of antitumor therapy [34]. Cell cycle regulation is the key to cell proliferation [35]. Ophiopogonin D significantly inhibits cell proliferation and colony formation in MCF-7 breast cancer cells [36]. In ophiopogonin D-induced cell cycle was arrested at the G2/M phase in MCF-7 cells when the expression level of cyclin B1 was decreased [36]. In addition, MTT assay indicated that Amana edulis (water-ethanol) mixed system extract may be involved in the inhibition of the antitumor effect.

In conclusion, our findings indicated that Amana edulis (water-ethanol) mixed system extract contained potential high-activity anticancer effects on liver cancer cells in vitro. However, the effects of Amana edulis in vivo need to be further studied and further separation of single active component is expected to research its effect target. Moreover, more attention should be paid to consideration to develop the new drugs derived from Amana edulis for the treatment of liver cancer. In the struggle against HCC, we need not only the wisdom but the knowledge to solve the fatal problems that have plagued the whole world.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

Authors’ Contributions

Yueyang Fan and Xiaowei Hou contributed equally to this work.

Acknowledgments

The authors thank JO TING NG for preparing 6 kinds of medicinal herbs in this manuscript. This research was supported in part by grants from National Natural Science Foundation of China (to YF, Project no. 81173388) and Medical and Health Technology Development Plan of Shandong Province, China (to YF, Project no. 2016WS0732).

References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, and J. Lortet-Tieulent, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at: Publisher Site | Google Scholar
  2. I. J. Lee and J. Seong, “Radiotherapeutic strategies in the management of hepatocellular carcinoma,” Oncology, vol. 81, no. 1, pp. 123–133, 2011. View at: Publisher Site | Google Scholar
  3. A. Villanueva, D. Y. Chiang, P. Newell et al., “Pivotal role of mTOR signaling in hepatocellular carcinoma,” Gastroenterology, vol. 135, no. 6, pp. 1972.e11–1983.e11, 2008. View at: Publisher Site | Google Scholar
  4. Z. Li and C. Xu, “The fundamental theory of traditional Chinese medicine and the consideration in its research strategy,” Frontiers of Medicine in China, vol. 5, no. 2, pp. 208–211, 2011. View at: Publisher Site | Google Scholar
  5. J. Zhao, P. Jiang, and W. Zhang, “Molecular networks for the study of TCM pharmacology,” Briefings in Bioinformatics, vol. 11, no. 4, pp. 417–430, 2009. View at: Publisher Site | Google Scholar
  6. S. Li, Z. Q. Zhang, L. J. Wu, X. G. Zhang, Y. D. Li, and Y. Y. Wang, “Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network,” IET Systems Biology, vol. 1, no. 1, pp. 51–60, 2007. View at: Publisher Site | Google Scholar
  7. J.-J. Wu, W.-Y. Sun, S.-S. Hu, S. Zhang, and W. Wei, “A standardized extract from Paeonia lactiflora and Astragalus membranaceus induces apoptosis and inhibits the proliferation, migration and invasion of human hepatoma cell lines,” International Journal of Oncology, vol. 43, no. 5, pp. 1643–1651, 2013. View at: Publisher Site | Google Scholar
  8. S. Gu and J. Pei, “Chinese Herbal Medicine Meets Biological Networks of Complex Diseases: A Computational Perspective,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, pp. 1–7, 2017. View at: Publisher Site | Google Scholar
  9. L. Ma, S. Wen, Y. Zhan, Y. He, X. Liu, and J. Jiang, “Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells,” Planta Medica, vol. 74, no. 3, pp. 245–251, 2008. View at: Publisher Site | Google Scholar
  10. S. Wang, Z. Zheng, Y. Weng et al., “Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts,” Life Sciences, vol. 74, no. 20, pp. 2467–2478, 2004. View at: Publisher Site | Google Scholar
  11. S. Lukman, Y. He, and S.-C. Hui, “Computational methods for traditional chinese medicine: a survey,” Computer Methods and Programs in Biomedicine, vol. 88, no. 3, pp. 283–294, 2007. View at: Publisher Site | Google Scholar
  12. X. Wang, N. Wang, F. Cheung, L. Lao, C. Li, and Y. Feng, “Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms,” Journal of Integrative Medicine, vol. 13, no. 3, pp. 142–164, 2015. View at: Publisher Site | Google Scholar
  13. M. Li, Y. Tang, L. Wu et al., “The hepatocyte-specific HNF4α/miR-122 pathway contributes to iron overload–mediated hepatic inflammation,” Blood, vol. 130, no. 8, pp. 1041–1051, 2017. View at: Publisher Site | Google Scholar
  14. S. Lin, L. Tian, H. Shen et al., “DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia,” Oncogene, vol. 32, no. 40, pp. 4845–4853, 2013. View at: Publisher Site | Google Scholar
  15. C. Ling, Z. Yin, J. Li, D. Zhang, G. Aslanidi, and A. Srivastava, “Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors,” Molecular Therapy - Methods & Clinical Development, vol. 3, p. 16029, 2016. View at: Publisher Site | Google Scholar
  16. C. Ling, K. Bhukhai, Z. Yin et al., “High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing,” Scientific Reports, vol. 6, no. 1, 2016. View at: Publisher Site | Google Scholar
  17. Y.-H. Zhang, Y. Wang, A. H. Yusufali et al., “Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivo,” Journal of Integrative Medicine, vol. 12, no. 6, pp. 483–494, 2014. View at: Publisher Site | Google Scholar
  18. B. H. Han, Y. J. Lee, J. J. Yoon et al., “Hwangryunhaedoktang exerts anti-inflammation on LPS-induced NO production by suppressing MAPK and NF-κB activation in RAW264.7 macrophages,” Journal of Integrative Medicine, vol. 15, no. 4, pp. 326–336, 2017. View at: Publisher Site | Google Scholar
  19. R. Sayroo, D. Nolasco, Z. Yin et al., “Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells,” Gene Therapy, vol. 23, no. 1, pp. 18–25, 2016. View at: Publisher Site | Google Scholar
  20. L. P. Vu, B. F. Pickering, Y. Cheng et al., “The N 6 -methyladenosine (m 6 A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells,” Nature Medicine, vol. 23, no. 11, pp. 1369–1376, 2017. View at: Publisher Site | Google Scholar
  21. C. Ling, B. Li, W. Ma, and A. Srivastava, “Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses,” Human Gene Therapy Methods, vol. 27, no. 4, pp. 143–149, 2016. View at: Publisher Site | Google Scholar
  22. J.-M. Lu, D.-D. Liu, Z.-Y. Li, C. Ling, and Y.-A. Mei, “Neuritin Enhances Synaptic Transmission in Medial Prefrontal Cortex in Mice by Increasing Ca v 3.3 Surface Expression,” Cerebral Cortex, vol. 27, no. 7, pp. 3842–3855, 2017. View at: Publisher Site | Google Scholar
  23. M. U. Rehman, “An impending cancer crisis in developing countries: are we ready for the challenge?” Asian Pacific Journal of Cancer Prevention, vol. 10, no. 4, pp. 719–20, 2009. View at: Google Scholar
  24. M. Xiang, H. Su, Y. Hu, Y. Hu, T. Yang, and G. Shu, “Chemical composition of total flavonoids from Salvia chinensia Benth and their pro-apoptotic effect on hepatocellular carcinoma cells: potential roles of suppressing cellular NF-κB signaling,” Food and Chemical Toxicology, vol. 62, pp. 420–426, 2013. View at: Publisher Site | Google Scholar
  25. C. Verslype and L. Libbrecht, “The diagnostic and therapeutic approach for primary solid liver tumours in adults,” Best Practice & Research Clinical Gastroenterology, vol. 21, no. 6, pp. 983–996, 2007. View at: Publisher Site | Google Scholar
  26. C.-T. Ting, C.-J. Kuo, H.-Y. Hu, Y.-L. Lee, and T.-H. Tsai, “Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: A cross-sectional analysis of the National Health Insurance Research Database,” BMC Complementary and Alternative Medicine, vol. 17, no. 1, article no. 118, 2017. View at: Publisher Site | Google Scholar
  27. X. Y. Hu et al., “Mechanism of apoptosis in human leukemia NB4 cells induced by total astragalosides,” Zhonghua Zhong Liu Za Zhi, vol. 33, no. 5, p. 345, 2011. View at: Google Scholar
  28. X. Liu et al., “Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell,” Journal of Gastroenterology and Hepatology, vol. 25, no. 2, p. 420, 2010. View at: Google Scholar
  29. P. Wang, Z. Li, L. Fu et al., “Effects of extracts of Prunella Vulgaris L. on proteome of human lung adenocarcinoma cell line A549,” Zhonghua Yi Xue Za Zhi, vol. 94, no. 28, pp. 2216–2221, 2014. View at: Google Scholar
  30. H.-J. Zhang, L.-N. Li, J. Zhou et al., “Effects of Gnaphalium affine D. Don on hyperuricemia and acute gouty arthritis,” Journal of Ethnopharmacology, vol. 203, pp. 304–311, 2017. View at: Publisher Site | Google Scholar
  31. Z. ZHANG, H. LI, F. WAN et al., “Polysaccharides extracted from the roots of Bupleurum chinense DC modulates macrophage functions,” Chinese Journal of Natural Medicines, vol. 15, no. 12, pp. 889–898, 2017. View at: Publisher Site | Google Scholar
  32. C.-C. Shih, C.-H. Lin, and W.-L. Lin, “Ameliorative effects of Vaccaria segetalis extract on osteopenia in ovariectomized rats,” Journal of Natural Medicines, vol. 63, no. 4, pp. 386–392, 2009. View at: Publisher Site | Google Scholar
  33. D. Zhao, M. Cheng, W. Tang et al., “Nano-silver modifies the vase life of cut herbaceous peony (Paeonia lactiflora Pall.) flowers,” Protoplasma. View at: Publisher Site | Google Scholar
  34. Y. Liu, Y. Cao, W. Zhang et al., “A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo,” Molecular Cancer Therapeutics, vol. 11, no. 8, pp. 1672–1682, 2012. View at: Publisher Site | Google Scholar
  35. J. Zhang, X. Zhu, H. Li et al., “Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression,” International Immunopharmacology, vol. 24, no. 1, pp. 50–58, 2015. View at: Publisher Site | Google Scholar
  36. Q. Zang, L. Zhang, N. Gao, and C. Huang, “Ophiopogonin D inhibits cell proliferation, causes cell cycle arrest at G2/M, and induces apoptosis in human breast carcinoma MCF-7 cells,” Journal of Integrative Medicine, vol. 14, no. 1, pp. 51–59, 2016. View at: Publisher Site | Google Scholar

Copyright © 2018 Yueyang Fan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1116 Views | 373 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.